Search Results

Your search for Supriya Chopra, MD matches 2 pages

Showing 1 - 2

By The ASCO Post Staff / SGO 2021 Virtual Annual Meeting on Womens Cancer

Supriya Chopra, MD, on Cervical Cancer: Reducing Late Effects of Bowel Toxicity

Supriya Chopra, MD, of Tata Memorial Centre, discusses a final analysis of the phase III PARCER trial, which showed that image-guided intensity-modulated radiotherapy is superior to conventional radiotherapy in reducing bowel toxicity in women with cervical cancer. Acute diarrhea was also reduced,...

gynecologic cancers

By Supriya Chopra, MD / 2015 ASTRO Annual Meeting

Supriya Chopra, MD, on Reducing Late Bowel Toxicity in Cervical Cancer

Supriya Chopra, MD, of Tata Memorial Hospital, discusses results of the PARCER study, which compared conventional 3D conformal radiotherapy to image-guided intensity-modulated radiotherapy in reducing bowel side effects for women with cervical cancer (Abstract 8).

Apr

Today In Oncology

Search Results

Your search for Supriya Chopra, MD matches 2 pages

Supriya Chopra, MD, on Cervical Cancer: Reducing Late Effects of Bowel Toxicity

Supriya Chopra, MD, on Reducing Late Bowel Toxicity in Cervical Cancer

Progression-Free Survival Benefit Confirmed With Triplet Combination in BRCA Wild-Type, HRD-Positive Ovarian Cancer

Insights From the 2023 International Society of Geriatric Oncology Conference

Illuminating a Potential Culprit in Melanoma Treatment Resistance

Oxaliplatin-Based Adjuvant Therapy in Older Patients with Stage III Colon Cancer

Newly Diagnosed Locally Advanced HNSCC Adding Pembrolizumab to Concurrent Chemoradiotherapy